Stockreport

NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx

NexGel, Inc  (NXGL) 
PDF NEXGEL shareholders will receive a non-dilutive 19.99% equity interest in NexGelRx up to $8 million of capital investment in spin-off NEXGEL will also receive a 5% glob [Read more]